Carcinoma, Ovarian Epithelial D000077216

Related MeSH Hierarchy (8)

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Ovarian Epithelial

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial

Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial

Diseases [C] » Endocrine System Diseases [C19] » Gonadal Disorders » Ovarian Diseases » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial

Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Female » Adnexal Diseases » Ovarian Diseases » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Female » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial

Description

A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.   MeSH

Hierarchy View


Approved Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 3 Indications (141)

Organization Involved with Phase 2 Indications (341)

Abbott

AbbVie

AB Science

Accenture

Accord Research

Acerta Pharma

Adaptimmune

Advent Health

Alcedis GmbH

AltaRex

Amarex Clinical Research

American Society of Clinical Oncology

Anchiano Therapeutics

Ångstrom Pharmaceuticals

Anhui Medical University

Apotex

Aprea Therapeutics AB

Aqualis

Aravive Biologics

Asian Gynecologic Oncology Group

Assiut University

Astellas

Astex Pharmaceuticals, Inc.

Austin Health

AVAX Technologies

Aventis

Baxalta

Bayer

Baylor University

Billings Clinic

Biogen

Bionomics Limited

Boehringer Ingelheim

Boston Biomedical

Burzynski Research Institute

Caladrius Biosciences

California Cancer Center

Cancer Research Institute

Cancer Treatment Research Foundation

CASI Pharmaceuticals, Inc.

Catalysis SL

Catholic University of Korea

Catholic University of Sacred Heart, Rome

Cedars-Sinai Medical Center

Celgene

Cellectar, Inc

Celsion

Centre Georges Francois Leclerc

Cephalon

Chang Gung University

Chao Family Comprehensive Cancer Center

Charles University

Chipscreen Biosciences, Ltd.

Chong Kun Dang Pharmaceutical

City of Hope National Medical Center

ClinAssess GmbH

Columbia University

Context Therapeutics

Corporacion Parc Tauli

Cristal Therapeutics

CTI BioPharma

Curie Institute

Cytran

Daiichi Sankyo

Dutch Cancer Society

East and North Hertfordshire NHS Trust

ECOG-ACRIN Cancer Research Group

Eisai

Eleison Pharmaceuticals

Eli Lilly

Ellipses Pharma

Emek Medical Center

EpicentRx, Inc.

Esperance Pharmaceuticals Inc

European Commission

European Interbalkan Medical Center

ExcellaBio LLC

Exelixis

Facet Biotech

Free University of Brussels

French Cancer Research Hospital Program

Fresenius

Fundacion Instituto Valenciano de Oncologia

Gabrail Cancer Center

Garden State Cancer Center

GCIG: Gynecologic Cancer InterGroup

Genentech

Genmab

Genzyme

Georgetown University

George Washington University

Georgia Institute of Technology

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Ghent University

GlaxoSmithKline

Glycotope GmbH

Government of Canada

Government of France

Government of Singapore

Griffith University

Groupe Hospitalier Diaconesses Croix Saint Simon

Gynecologic Oncology Associates

Gynecologic Oncology Trial and Investigation Consortium, Japan

Harbin Medical University

Harrington Cancer Center

Hebrew University

Hellenic Cooperative Oncology Group

Hellenic Oncology Research Group

Hemispherx Biopharma

Henry M. Jackson Foundation for the Advancement of Military Medicine

Herbert Irving Comprehensive Cancer Center

Hoosier Cancer Research Network

Hospital A.C. Camargo

Hospital La Paz

Hospital Universitario Fundación Alcorcón

Hospital Universitari Son Dureta

HSK Research GmbH Wiesbaden

Icahn School of Medicine at Mount Sinai

Immetacyte

Immune System Key Ltd

Immunitor LLC

Immunomedics

Immutep S.A.

INC Research

Incyte

Indiana University

Innovation Pharmaceuticals

Inova Health System

Institut Gustave Roussy

Instituto de Medicina Integral Professor Fernando Figueira

Instituto Europeo de Oncologia

InterMune

Iovance

Iowa Methodist Medical Center

ISA Pharmaceuticals

ISTITUTO REGINA ELENA

James Graham Brown Cancer Center

Janssen Pharmaceutica NV

Jarrow Formulas Inc

Jiangsu Cancer Institute & Hospital

Jilin Provincial Tumor Hospital

Jinan University

Jubilant Innovation Ltd.

Kaiser Permanente

Kazia Therapeutics Limited

K-Group Beta

Kintara Therapeutics, Inc.

KK Women's and Children's Hospital

Klus Pharma Inc.

Krankenhaus der Barmherzigen Schwestern Linz

KuDOS

Kunming Medical University

Laekna Limited

Latin American Cooperative Oncology Group

Laval University

Leap Therapeutics, Inc.

Leiden University

LifeBridge Health

Ludwig Institute for Cancer Research

Mackay Medical College

Marin Cancer Care

Mary Crowley Cancer Center

Mayo Clinic

McMaster University

Medical College of Wisconsin

Medical University Innsbruck

Medical University of South Carolina

MedImmune

Memorial Health University Medical Center

Memorial Sloan-Kettering Cancer Center

Merck KGaA

Merck Serono

Mercy Medical Center

Merrimack Pharmaceuticals

Mersana Therapeutics

Mid-Atlantic Gynecologic Oncology & Pelvic Surgical Associates

Millennium Pharmaceuticals

MolMed S.p.A.

Morristown Memorial Hospital

Mount Sinai Hospital, Canada

Nanjing Medical University

NanOlogy, LLC

NantWorks

National Cheng Kung University

National Comprehensive Cancer Network

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

National University of Singapore

Nektar Therapeutics

Neovii Biotech

Newcastle University

NewLink Genetics Inc

New Mexico Cancer Care Alliance

NewVac LLC

New York Presbyterian Hospital

New York University

Nine Girls Ask

Novartis

NovoCure Ltd.

Novo Nordisk

Nucana

OBI Pharma, Inc

OncoGenex Technologies

Oncology Venture

Onconova Therapeutics, Inc.

On Target Laboratories, LLC

Ontario Institute for Cancer Research

Onxeo

Ortho Biotech, Inc.

Osaka University

OSI Pharmaceuticals

Oxford BioMedica

People's Hospital of Leshan

Peter MacCallum Cancer Centre

PharmaBio Development Inc.

Philipps University of Marburg

Plexxikon

Premiere Oncology

Prescient Therapeutics, Ltd.

PsiOxus Therapeutics Ltd

Qingfeng Pharmaceutical Group

Quest PharmaTech Inc.

Regeneron

Region Syddanmark

Royal Marsden Hospital NHS Trust

R-Pharm

Ruhr University Bochum

Russian Academy of Medical Sciences

Rutgers University

Samyang Biopharmaceuticals Corporation

San Antonio Military Medical Center

Sanofi

Scripps

Seattle Genetics

Seoul National University

Shanghai Gynecologic Oncology Group

Shantou University

Shenzhen Geno-Immune Medical Institute

Shenzhen Hank Bioengineering Institute

Shenzhen SiBiono GeneTech Co.,Ltd

SmithKline Beecham

Soochow University

Southeastern Gynecologic Oncology

South Plains Oncology Consortium

State University of New York, Buffalo

St. Joseph's Hospital and Medical Center - Phoenix, Arizona

Sunesis Pharmaceuticals

Sungkyunkwan University

Suzhou Medical College

Symphony Capital

Syndax Pharmaceuticals

Synteract, Inc.

Taiwanese Gynecologic Oncology Group

Takeda

Tapimmune Inc.

Technion University

Tel Aviv University

Temple University

TetraLogic Pharmaceuticals

Texas Tech University

The Cancer Research Society

The Christie NHS Foundation Trust

The First People's Hospital of Changzhou

The University of Hong Kong

The University of Texas, Dallas

Thomas Jefferson University

Translational Research in Oncology

United States Army

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universidad de Cordoba

Universitätsklinikum Mannheim, Frauenklinik

University of Adelaide

University of Alabama, Birmingham

University of Alberta

University of Birmingham

University of Bologna

University of Brescia

University of Caen-Normandie

University of California, Irvine

University of California, San Diego

University of California, San Francisco

University of Cantabria

University of Crete

University of Groningen

University of Haifa

University of Heidelberg

University of Illinois

University of Iowa

University of Kansas

University of Lausanne

University of Leicester

University of Liverpool

University of Louisville

University of Maryland

University of Melbourne

University of Miami

University of Minnesota

University of Montpellier

University of Montreal

University of New Mexico

University of North Carolina at Chapel Hill

University of Ottawa

University of Oxford

University of Pennsylvania

University of Pittsburgh

University of Queensland

University of South Carolina

University of Southern California

University of Southern Denmark

University of South Florida

University of Sydney

University of Tennessee

University of Texas at Houston

University of Texas, San Antonio

University of Toronto

University of Ulsan

University of Utah

University of Valencia

University of Virginia

University of Warwick

University of Washington

University of Western Australia

University of Western Ontario

University of Wisconsin

University of Zaragoza

US Biotest

VentiRx Pharmaceuticals Inc.

Verastem, Inc.

Virginia Mason Medical Center

Vita-Salute University of Milano. Italy

Wake Forest University

Warwick Medical School

Washington University in St. Louis

Wayne State University

WiSP GmbH

Xiamen University

Yale University

Yeshiva University

Yiling Pharmaceutical Inc.

Yonsei University

Organization Involved with Phase 1 Indications (87)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.